HSV Management in a 10-Year-Old Female, 26 kg
For this 10-year-old patient weighing 26 kg, treat with oral acyclovir 20 mg/kg per dose (maximum 400 mg/dose) three times daily for 5-14 days, depending on the severity and type of HSV infection. 1
Treatment Algorithm by Clinical Presentation
Mild Mucocutaneous Disease (Cold Sores, Mild Genital Herpes)
- Oral acyclovir: 20 mg/kg/dose (max 400 mg) three times daily for 5-10 days 1
- For this 26 kg patient: approximately 520 mg per dose, so give 400 mg three times daily (capped at maximum)
- This is appropriate for mild gingivostomatitis or localized skin lesions
Moderate to Severe Gingivostomatitis
- Start with IV acyclovir: 5-10 mg/kg/dose three times daily 1
- For this patient: 130-260 mg IV three times daily
- Switch to oral acyclovir once lesions begin to regress and continue until complete healing 1
- This stepdown approach reduces morbidity while avoiding unnecessary hospitalization
Genital Herpes (Primary Episode)
Since this patient weighs <45 kg:
- Oral acyclovir: 20 mg/kg/dose (max 400 mg) three times daily for 5-14 days 1
- Duration depends on severity: 5 days for mild cases, up to 14 days for more severe presentations
- Important consideration: Assess for sexual abuse if genital HSV is diagnosed in this age group
CNS or Disseminated Disease (Encephalitis, Meningitis)
- IV acyclovir: 10 mg/kg three times daily for 21 days 1
- For this patient: 260 mg IV three times daily
- This is a medical emergency requiring immediate hospitalization
- Do not use oral therapy for CNS involvement
Key Clinical Considerations
Renal Function Monitoring:
- Acyclovir is renally excreted; ensure adequate hydration 2
- Monitor for nephrotoxicity, especially with IV administration
- Adjust dosing if renal insufficiency develops
Common Pitfalls to Avoid:
- Do not underdose: The 20 mg/kg dosing is critical for adequate viral suppression in children 1
- Do not use adult dosing: The 400 mg twice daily adult regimen is inadequate for children <45 kg 1
- Do not use valacyclovir or famciclovir: These lack pediatric formulations and dosing data for this age group 1
Duration Matters:
- Mild cases: 5-7 days typically sufficient
- Moderate cases: 7-10 days
- Severe or first-episode genital herpes: up to 14 days 1
Alternative Therapy (Acyclovir-Resistant HSV)
If the patient fails to respond after 7-10 days or has documented resistance:
- IV foscarnet: 40 mg/kg three times daily OR 60 mg/kg twice daily 1
- For this patient: approximately 1040 mg three times daily or 1560 mg twice daily
- Requires slow infusion over 2 hours with saline hydration to minimize renal toxicity 2
- This scenario is rare in immunocompetent children but more common in HIV-infected or otherwise immunocompromised patients
Suppressive Therapy Consideration
For recurrent HSV (>3-6 severe episodes per year):
- Oral acyclovir suppression can be considered 2
- However, this is uncommon in immunocompetent children
- Requires careful monitoring for neutropenia with long-term use 2
Evidence Quality Note
The recommendations are based on CDC/NIH/IDSA/PIDS/AAP guidelines from 2009 1 and 2004 2, which remain the authoritative pediatric HSV treatment guidelines. These carry AI and AII evidence ratings, indicating strong recommendations based on at least one randomized trial or strong observational data. The weight-based dosing approach is critical in pediatrics and differs substantially from adult fixed-dose regimens.